フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
0001372514false00013725142023-06-212023-06-21UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549FORM 8-KCURRENT REPORT PURSUANTTO...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Filed Pursuant to Rule 424(b)(1) Registration No. 333-271699PROSPECTUS 1,447,628 Shares of Common Stock3,908 Shares...
As filed with the Securities and Exchange Commission on May 31, 2023Registration No. 333-271699 ...
Kiora Pharmaceuticals, Inc. NASDAQ: KPRX Q2 2023 | Corporate Overview Filed pursuant to Rule 433 under the Securities Act of 1933, as...
0001372514false00013725142023-05-092023-05-09UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549FORM 8-KCURRENT REPORT PURSUANTTO...
0001372514--12-312023Q1false0.0250.025330.67330.6700013725142023-01-012023-03-3100013725142023-05-05xbrli:shares00013725142023-03-31iso4217:USD0001...
As filed with the Securities and Exchange Commission on May 5, 2023Registration No. 333- ...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549SCHEDULE 14A(Rule 14a-101)INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE...
0001372514false00013725142023-03-232023-03-23UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549FORM 8-KCURRENT REPORT PURSUANTTO...
0001372514false00013725142023-03-242023-03-24UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549FORM 8-KCURRENT REPORT...
00013725142022FYfalse0.0255.50.025330.67330.6700013725142022-01-012022-12-3100013725142022-06-30iso4217:USD00013...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-269570 PROSPECTUS Up to 1,052,798...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約